Page 33 - Clean India Journal Magazine June 2019 Issue

MARKET REPORT

n India, pharma manufacturing clusters are
located in Maharashtra (Mumbai-Pune and
IAurangabad), Gujarat (Ahmedabad-Vadodara),
Delhi-UP, Haryana, Madhya Pradesh (Indore)
Uttarakhand (Dehradun), Andhra Pradesh
(Hyderabad-Medak), and Odisha (Cuttack-
Bhubaneswar). Over the last five years, the
pharma sector has been growing at a compounded
annual growth rate (CAGR) of more than 15%.

Projected Future Growth
It is estimated that by 2020, the prevalence of
chronic or long-term diseases such as diabetes
and cancer will increase by 25-40%. These
will require ramped-up manufacturing of drugs
which can manage them over months and years.
Corporate hospital chains will expand their At present, four of the top ten players in the pharma
hospital network in the top 70 cities; hub-and-spoke industry, including the market leader, are new entrants.
delivery models providing access to higher levels of care The Drug Controller General of India (DCGI) has
will rise within the top 200-250 towns. More and more announced its plans to start a single-window facility to
people will be able to access quality hospitals, which will provide approvals for setting up pharma manufacturing
drive the need for medication. centres, which will further encourage the entry of new
Rising incomes will drive 73 million households into ventures. It should come as no surprise that the industry is
the middle- and upper-income segments, expanding the set to grow to $50 billion by 2020, and likely to be in the
market of those who can afford to spend on medicines. top 10 global markets in terms of value.
Increased health insurance coverage will augment
affordability. By 2020, nearly 650 million people will Cleaning Requirements
enjoy health insurance coverage. Private insurance
coverage will grow by nearly 15 per cent annually till Now that we know the immense potential of this sector,
2020. However, the largest impact will be seen through we must not forget that few other sectors place the same
government sponsored programmes that are largely importance of cleanliness and hygiene as the pharma
sector. By law, they are required to do so; as businesses,
focused on the ‘below poverty line’ (BPL) segment,
and are expected to provide coverage to nearly 380 it is in their own best interests to ensure that their
million people by 2020. At the moment, the Ayushman products - which are consumed by sick people -- do not
Bharat mission provides 100 million poor families in cause sickness themselves. Over the years, the rigour of
the country with a cover of up to `5 lakh per below- cleanliness regimens in manufacturing plants has become
poverty-line family per year for secondary and tertiary increasingly stringent.
care hospitalisation. Since all this will reduce out-of- The core parts of a pharma manufacturing plant are
pocket expenses, medicines will be more frequently and the rooms in which different steps of the process like
regularly bought. granulation, blending, capsule filling, syrup filling, tablet

Clean India Journal
www.cleanindiajournal.com 33
June 2019